Advertisement

Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 600x80px
Document › Details

Bayer AG. (9/7/17). "Press Release: Bayer Submits Marketing Authorization Application for BAY94-9027 for the Treatment of Hemophilia A in the EU [Not intended for U.S. and UK Media]". Berlin.

Region Region EU (European Union)
Organisations Organisation Bayer AG
  Group Bayer (Group)
  Organisation 2 EMA (European Medicines Agency)
  Group EU (govt)
Products Product damoctocog alpha pegol (BAY 94-9027) (long-acting PEGylated rFVIII)
  Product 2 protein pegylation
Person Person Möller, Jörg (Bayer 201403 Bayer HealthCare Head of Global Development)
     


   
Record changed: 2017-09-18

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 600x80px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px